Biodistribution of tumor-targeted MXene-antibody conjugates

Authors:

Abstract
An antibody-functionalized MXene-polydopamine nanoplatform enables intratumoral and intravenous in vivo tumor targeting with minimal off-target accumulation in clearance organs, supporting safe and effective cancer therapy.
Funding Information
  • Horizon 2020 Framework Programme (101086184)

This publication has 59 references indexed in Scilit: